Cigna Group (CI)
(Delayed Data from NYSE)
$356.14 USD
-1.12 (-0.31%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $356.09 -0.05 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Cigna Group falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 5,372.00 | 6,746.00 | 5,415.00 | 8,489.00 | 5,120.00 |
Depreciation/Amortization & Depletion | 3,035.00 | 2,937.00 | 2,923.00 | 2,802.00 | 3,651.00 |
Net Change from Assets/Liabilities | 3,488.00 | 620.00 | -872.00 | 3,598.00 | 1,202.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -82.00 | -1,647.00 | -275.00 | -4,539.00 | -488.00 |
Net Cash From Operating Activities | 11,813.00 | 8,656.00 | 7,191.00 | 10,350.00 | 9,485.00 |
Property & Equipment | -1,573.00 | -1,295.00 | -1,154.00 | -1,094.00 | -1,050.00 |
Acquisition/ Disposition of Subsidiaries | -434.00 | 4,835.00 | -1,894.00 | 5,453.00 | -153.00 |
Investments | -2,835.00 | -272.00 | -660.00 | -1,406.00 | 480.00 |
Other Investing Activities | -332.00 | -170.00 | 97.00 | 23.00 | -11.00 |
Net Cash from Investing Activities | -5,174.00 | 3,098.00 | -3,611.00 | 2,976.00 | -734.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,097.00 | -7,218.00 | -7,416.00 | -3,666.00 | -1,763.00 |
Issuance (Repayment) of Debt | -1,476.00 | -500.00 | -454.00 | -4,796.00 | -4,494.00 |
Increase (Decrease) Short-Term Debt | 1,198.00 | -2,059.00 | 975.00 | 60.00 | -681.00 |
Payment of Dividends & Other Distributions | -1,450.00 | -1,384.00 | -1,341.00 | 0.00 | 0.00 |
Other Financing Activities | -469.00 | -79.00 | 24.00 | -131.00 | -249.00 |
Net Cash from Financing Activities | -4,294.00 | -11,240.00 | -8,212.00 | -8,533.00 | -7,187.00 |
Effect of Exchange Rate Changes | 16.00 | -86.00 | -65.00 | 41.00 | -8.00 |
Net Change In Cash & Equivalents | 2,361.00 | 428.00 | -4,697.00 | 4,834.00 | 1,556.00 |
Cash at Beginning of Period | 5,976.00 | 5,548.00 | 10,245.00 | 5,411.00 | 3,855.00 |
Cash at End of Period | 8,337.00 | 5,976.00 | 5,548.00 | 10,245.00 | 5,411.00 |
Diluted Net EPS | 17.39 | 21.30 | 15.73 | 22.96 | 13.44 |
Fiscal Year End for Cigna Group falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1,417.00 | -212.00 | 5,372.00 | 4,265.00 | 2,816.00 |
Depreciation/Amortization & Depletion | 1,479.00 | 741.00 | 3,035.00 | 2,270.00 | 1,504.00 |
Net Change from Assets/Liabilities | 505.00 | 2,558.00 | 3,488.00 | 4,049.00 | 3,377.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1,704.00 | 1,753.00 | -82.00 | -238.00 | -177.00 |
Net Cash From Operating Activities | 5,105.00 | 4,840.00 | 11,813.00 | 10,346.00 | 7,520.00 |
Property & Equipment | -670.00 | -300.00 | -1,573.00 | -1,208.00 | -805.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -434.00 | -430.00 | 27.00 |
Investments | -115.00 | -83.00 | -2,835.00 | -2,979.00 | -2,540.00 |
Other Investing Activities | -350.00 | -112.00 | -332.00 | -117.00 | -79.00 |
Net Cash from Investing Activities | -1,135.00 | -495.00 | -5,174.00 | -4,734.00 | -3,397.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -4,791.00 | -3,841.00 | -2,097.00 | -1,627.00 | -1,057.00 |
Issuance (Repayment) of Debt | 1,462.00 | 2,252.00 | -1,476.00 | -1,476.00 | 1,411.00 |
Increase (Decrease) Short-Term Debt | -467.00 | -364.00 | 1,198.00 | 1,484.00 | 183.00 |
Payment of Dividends & Other Distributions | -793.00 | -401.00 | -1,450.00 | -1,092.00 | -730.00 |
Other Financing Activities | -249.00 | -175.00 | -469.00 | -333.00 | -279.00 |
Net Cash from Financing Activities | -4,838.00 | -2,529.00 | -4,294.00 | -3,044.00 | -472.00 |
Effect of Exchange Rate Changes | -12.00 | -9.00 | 16.00 | 2.00 | 9.00 |
Net Change In Cash & Equivalents | -880.00 | 1,807.00 | 2,361.00 | 2,570.00 | 3,660.00 |
Cash at Beginning of Period | 8,337.00 | 8,337.00 | 5,976.00 | 5,976.00 | 5,976.00 |
Cash at End of Period | 7,457.00 | 10,144.00 | 8,337.00 | 8,546.00 | 9,636.00 |
Diluted Net EPS | 5.45 | -0.97 | 3.49 | 4.74 | 4.92 |